This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West

Early Registration Savings Deadline Expires In:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event
Live In-Person Event March 14-17, 2022 at the San Diego Convention CenterWith Live Digital Panel Discussions March 22-24, 2022

Ying Huang
Sr. Principal Scientist, Biologics Process Research & Development at Merck

Profile

Dr. Huang is currently a Sr. Principal Scientist at Merck Research Labs, managing a group responsible for cell line development and GMP cell banking to support Merck biologics portfolio. Dr. Huang received her PhD degree in Molecular Biology from the University of Tokyo, Japan. She has 15 years’ experience in the biotherapeutic/vaccine discovery and production. She has worked at Eli Lilly, NIH, Thermo Fisher Scientific, and KBI Biopharma. Prior to Merck, Dr. Huang was at GSK Vaccines where she led a Protein Expression, Purification and Characterization Lab in preclinical R&D to support recombinant subunit or mRNA vaccine development.

Agenda Sessions

  • Development of biotherapeutic cell lines for continuous manufacturing

    2:00pm